• Quality competition with profit constraints : do non-profit firms provide higher quality than for-profit firms? 

      Brekke, Kurt Richard; Siciliani, Luigi; Straume, Odd Rune (Discussion paper, Working paper, 2011-02)
    • Reference pricing of pharmaceuticals 

      Brekke, Kurt Richard; Königbauer, Ingrid; Straume, Odd Rune (Discussion paper, Working paper, 2005-11)
      We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection ...
    • Reference pricing with endogenous generic entry 

      Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune (Discussion paper;04/15, Working paper, 2015-03)
      In this paper we study the effect of reference pricing on pharmaceutical prices and expenditures when generic entry is endogenously determined. We develop a Salop-type model where a brand-name producer competes with generic ...
    • Regulation, generic competition and pharmaceutical prices : theory and evidence from a natural experiment 

      Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune (Discussion paper, Working paper, 2007-12)
      We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample ...
    • Socioeconomic Status and Physicians’ Treatment Decisions 

      Brekke, Kurt R.; Holmås, Tor Helge; Monstad, Karin; Straume, Odd Rune (Discussion paper;12/15, Working paper, 2015-06)
      This paper aims at shedding light on the social gradient by studying the relationship between socioeconomic status (SES) and provision of health care. Using administrative data on services provided by General Practitioners ...
    • Strategisk regulering av gasstransport 

      Nese, Gjermund; Straume, Odd Rune (Arbeidsnotat, Working paper, 2005-02)
      EU retter gjennom sine gassmarkedsdirektiver stadig sterkere fokus på å øke konkurransen i det europeiske gassmarkedet. Et vesentlig aspekt for Norge som en stor gasseksportør er om økt konkurranse kan medføre at en ...
    • Taking the competitor’s pill: when combination therapies enter pharmaceutical markets 

      Brekke, Kurt R.; Dalen, Dag Morten; Straume, Odd Rune (DP SAM;19/2023, Working paper, 2023-11-22)
      We study the competitive effects of combination therapies in pharmaceutical markets, which crucially hinge on the additional therapeutic value of combinatory use of drugs and the therapeutic substitutability with the most ...